Rochester,NY 9/1/2009 12:40:17 AM
YM BioSciences Inc. YMI, YM BioSciences shares are rapidly increasing on U.S. cancer trial.
YM BioSciences Inc.
YM BioSciences has been given license for the development of cancer treatment in United States of America. The company said that it will get permission to commercialize the medic drugs in the market, which sends the shares up 100%.
The company was only permitted under U.S. restrictions on drugs that from Cuba, which allows only to import medic drug goods into the country for the brain caner in children studies to import the drug into the country for studies on brain cancer in children under U.S. restrictions on drugs that originated in Cuba.
About Stock EinsteinStockEinstein uses proprietary technologies coupled with years of experience to uncover stocks we feel have the greatest potential for breakout performance. We utilize not only software, but time tested criteria to uncover these potential winners. When these benchmarks are reached or exceeded, our subscribers are immediately notified.
This service is free and available only to subscribers. Scroll to the bottom of this page to signup for free stock alerts and visit our site.
Disclaimer: Full disclaimer at http://StockEinsteain.com/disclaimer.php
IMPORTANT: Never invest in any stock featured in any press release, email or website unless you can afford the loss of your entire investment. Stocks and particularly penny stocks have the possibility for dramatic gains, and also losses. Neither StockEinsteain, nor any of its affiliates are registered investment advisors or broker dealers.
